1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
Company has started the business of trading crude palm oil type A (CPOA) since October 2018, and planned to expand the scope of its crude palm oil business, which will help boost the revenues and ensure the
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
305 296 280 271 264 Prepaid 213 201 190 169 163 Blended 226 215 205 186 181 VOU (GB/data sub/month) Postpaid 4.1 5.0 5.7 6.7 7.5 Prepaid 2.7 3.2 3.5 4.1 5.4 Blended 3.0 3.6 4.0 4.7 5.9 Device
. Customers were required to commit to a certain price plan to improve ARPU level through data and device bunding packages. Meanwhile, there were campaigns and offerings in prepaid segment at a minimal scale
boost up of raw material cost cause from the demand over supply in electronic commodity market in 2018, together with higher inventory provision, moreover, the increasing in depreciation caused by the
result, the average ARPU from October 2017 has continued to increase. In addition, the company has offered new services and marketing promotion champagne to boost usage amount through Bonnterm kiosk